GlassScriptPhysician profile
Craig A Salcido
NPI 1316027857
$2,644.50
in general payments reported to CMS, 2019-2025
27 companies · $488 in 2025
The $488 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $150 · 2021: $404 · 2022: $504 · 2023: $378 · 2024: $152 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $730.85 | 2019-2023 | Lo Loestrin Fe |
| Siemens Medical Solutions USA, INC. | $214.48 | 2023-2025 | Embozene, Microthermx Microwave Ablation System, Oncozene |
| Janssen Pharmaceuticals, INC | $167.41 | 2025 | Spravato |
| Astellas Pharma US INC | $150.63 | 2019-2025 | Veozah |
| Biogen, INC. | $145.12 | 2024-2025 | Zurzuvae |
| Lupin INC. | $134.36 | 2019 | |
| Pfizer INC. | $131.60 | 2020-2025 | |
| Exeltis, USA INC. | $119.17 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $111.74 | 2019-2023 | Aptima |
| Aspira Women'S Health INC | $104.19 | 2022 | |
| Mayne Pharma Commercial LLC | $76.73 | 2022-2025 | |
| Organon LLC | $60.54 | 2022-2025 | Nexplanon |
| Exact Sciences Corporation | $58.64 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $51.59 | 2019-2022 | |
| Allergan, INC. | $49.41 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $48.74 | 2023-2025 | Gemtesa, Myfembree |
| Channel Medsystems, INC. | $43.41 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $36.98 | 2019-2020 | |
| Evofem Biosciences, INC. | $34.22 | 2022 | |
| Shield Therapeutics INC | $33.73 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $33.35 | 2022-2023 | Vivjoa |
| Minerva Surgical, INC | $23.49 | 2023 | |
| Therapeuticsmd, INC. | $22.47 | 2021 | |
| Daiichi Sankyo INC. | $20.53 | 2022 | |
| Radius Health, INC. | $16.80 | 2020 | |
| Ethicon US, LLC | $12.78 | 2019 | |
| Applied Medical Resources Corporation | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Salcido listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.